303 related articles for article (PubMed ID: 17868951)
1. Spatiotemporal control over growth factor signaling for therapeutic neovascularization.
Cao L; Mooney DJ
Adv Drug Deliv Rev; 2007 Nov; 59(13):1340-50. PubMed ID: 17868951
[TBL] [Abstract][Full Text] [Related]
2. Emerging technologies for enabling proangiogenic therapy.
Roy RS; Roy B; Sengupta S
Nanotechnology; 2011 Dec; 22(49):494004. PubMed ID: 22101316
[TBL] [Abstract][Full Text] [Related]
3. Current thoughts on angiogenesis.
Chan LK
J Wound Care; 2009 Jan; 18(1):12-4, 16. PubMed ID: 19131912
[TBL] [Abstract][Full Text] [Related]
4. Characterizing short-term release and neovascularization potential of multi-protein growth supplement delivered via alginate hollow fiber devices.
Tilakaratne HK; Hunter SK; Andracki ME; Benda JA; Rodgers VG
Biomaterials; 2007 Jan; 28(1):89-98. PubMed ID: 16952396
[TBL] [Abstract][Full Text] [Related]
5. Localized delivery of growth factors for angiogenesis and bone formation in tissue engineering.
Bai Y; Yin G; Huang Z; Liao X; Chen X; Yao Y; Pu X
Int Immunopharmacol; 2013 Jun; 16(2):214-23. PubMed ID: 23587487
[TBL] [Abstract][Full Text] [Related]
6. Protein-based signaling systems in tissue engineering.
Boontheekul T; Mooney DJ
Curr Opin Biotechnol; 2003 Oct; 14(5):559-65. PubMed ID: 14580589
[TBL] [Abstract][Full Text] [Related]
7. Heparan sulfate proteoglycans mediate the angiogenic activity of the vascular endothelial growth factor receptor-2 agonist gremlin.
Chiodelli P; Mitola S; Ravelli C; Oreste P; Rusnati M; Presta M
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):e116-27. PubMed ID: 21921258
[TBL] [Abstract][Full Text] [Related]
8. [Vascular endothelial growth factor--fundamental research and experimental study in plastic surgery].
Huang CY; Shen ZY
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 Jan; 16(1):64-9. PubMed ID: 11826659
[TBL] [Abstract][Full Text] [Related]
9. Molecular control of physiological skin angiogenesis.
Odorisio T; Failla CM; Zambruno G
Eur J Dermatol; 2002; 12(6):VII-X. PubMed ID: 12506892
[No Abstract] [Full Text] [Related]
10. Cardiovascular biology: signalling silenced.
Conway EM; Carmeliet P
Nature; 2003 Sep; 425(6954):139-41. PubMed ID: 12968163
[No Abstract] [Full Text] [Related]
11. Importance of dual delivery systems for bone tissue engineering.
Farokhi M; Mottaghitalab F; Shokrgozar MA; Ou KL; Mao C; Hosseinkhani H
J Control Release; 2016 Mar; 225():152-69. PubMed ID: 26805518
[TBL] [Abstract][Full Text] [Related]
12. Apelin enhances cardiac neovascularization after myocardial infarction by recruiting aplnr+ circulating cells.
Tempel D; de Boer M; van Deel ED; Haasdijk RA; Duncker DJ; Cheng C; Schulte-Merker S; Duckers HJ
Circ Res; 2012 Aug; 111(5):585-98. PubMed ID: 22753078
[TBL] [Abstract][Full Text] [Related]
13. In vivo absence of synergism between fibroblast growth factor-2 and vascular endothelial growth factor.
Nico B; de Falco G; Vacca A; Roncali L; Ribatti D
J Hematother Stem Cell Res; 2001 Dec; 10(6):905-12. PubMed ID: 11798517
[TBL] [Abstract][Full Text] [Related]
14. Essential factors associated with hepatic angiogenesis.
Das SK; Vasudevan DM
Life Sci; 2007 Nov; 81(23-24):1555-64. PubMed ID: 17950364
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic angiogenesis in the heart: protect and serve.
Molin D; Post MJ
Curr Opin Pharmacol; 2007 Apr; 7(2):158-63. PubMed ID: 17284359
[TBL] [Abstract][Full Text] [Related]
16. Towards therapeutic angiogenesis.
Singhal MK
Indian J Exp Biol; 2002 Mar; 40(3):373-4. PubMed ID: 12635717
[No Abstract] [Full Text] [Related]
17. Hybrid use of combined and sequential delivery of growth factors and ultrasound stimulation in porous multilayer composite scaffolds to promote both vascularization and bone formation in bone tissue engineering.
Yan H; Liu X; Zhu M; Luo G; Sun T; Peng Q; Zeng Y; Chen T; Wang Y; Liu K; Feng B; Weng J; Wang J
J Biomed Mater Res A; 2016 Jan; 104(1):195-208. PubMed ID: 26282063
[TBL] [Abstract][Full Text] [Related]
18. Engineered fibrin matrices for functional display of cell membrane-bound growth factor-like activities: study of angiogenic signaling by ephrin-B2.
Zisch AH; Zeisberger SM; Ehrbar M; Djonov V; Weber CC; Ziemiecki A; Pasquale EB; Hubbell JA
Biomaterials; 2004 Jul; 25(16):3245-57. PubMed ID: 14980419
[TBL] [Abstract][Full Text] [Related]
19. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments.
Lee K; Silva EA; Mooney DJ
J R Soc Interface; 2011 Feb; 8(55):153-70. PubMed ID: 20719768
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic neovascularization: contributions from bioengineering.
Brey EM; Uriel S; Greisler HP; McIntire LV
Tissue Eng; 2005; 11(3-4):567-84. PubMed ID: 15869435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
